Literature DB >> 21676923

Availability and use of Naswar: an exploratory study.

S Basharat1, S Kassim, R E Croucher.   

Abstract

BACKGROUND: Naswar is a niche smokeless tobacco product from Pakistan. There is little information about its availability and user characteristics.
METHODS: This cross-sectional survey identified outlets selling Naswar in two wards of one London borough and interviewed a purposively recruited sample of 73 Naswar purchasers. Data were analysed using descriptive and chi-square tests (significance, P ≤ 0.05).
RESULTS: Of 65 outlets identified 15 sold Naswar. The purchasers' mean (SD) age was 32 (± 10) years and 63% had completed only secondary education. Naswar consumption was significantly associated with tobacco dependency, whilst starting Naswar use at a younger age, having lower education levels, using Naswar more frequently and being of Pakhtunkhwa origin was associated with high monthly consumption (P ≤ 0.05).
CONCLUSIONS: Naswar was widely available. Naswar purchasers of Pakistani origin were employed and young, but with limited education and little knowledge of Naswar's health impacts. Naswar dependency and consumption was linked to behavioural and socio-demographic factors. Further evidence is needed to support policy development.

Entities:  

Mesh:

Year:  2011        PMID: 21676923     DOI: 10.1093/pubmed/fdr044

Source DB:  PubMed          Journal:  J Public Health (Oxf)        ISSN: 1741-3842            Impact factor:   2.341


  2 in total

1.  Oral cancer via the bargain bin: The risk of oral cancer associated with a smokeless tobacco product (Naswar).

Authors:  Zohaib Khan; Steffen Dreger; Syed Majid Hussain Shah; Hermann Pohlabeln; Sheraz Khan; Zakir Ullah; Basheer Rehman; Hajo Zeeb
Journal:  PLoS One       Date:  2017-07-10       Impact factor: 3.240

2.  Salivary Interleukin 1-beta levels and clinical periodontal parameters in habitual naswar users and non-users.

Authors:  Zaeem Arif Abbasi; Naila Irum Hadi; Adnan Mustafa Zubairi; Mervyn Hosein
Journal:  Pak J Med Sci       Date:  2019       Impact factor: 1.088

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.